Cervical Dysplasia Market

The cervical dysplasia market consists of diagnostic tests and devices used for the early detection of precancerous conditions in the cervix. The primary customers are healthcare providers, including hospitals, diagnostic centers, and ambulatory surgical centers. Key growth drivers include the rising global prevalence of cervical cancer, increased patient and governmental awareness initiatives promoting early diagnosis, and the strong link between HPV and the disease.